Company Filing History:
2 out of 975 
2 out of 108 
2 out of 83 
Years Active: 2013-2016
Title: Innovations of Jason A Davy
Introduction
Jason A Davy is a notable inventor based in Guelph, Canada. He has made significant contributions to the field of synthetic lung surfactants, with a focus on improving treatments for lung tissue dysfunction. His work has led to the development of innovative compositions that have the potential to enhance respiratory therapies.
Latest Patents
Jason A Davy holds two patents related to synthetic lung surfactant compositions. His latest patents describe compositions that include phospholipase-resistant phospho-glycerol derivatives, phospholipase-resistant phospho-choline derivatives, and surface-active proteins or peptides. These compositions are designed to treat endogenous surfactant dysfunctional or deficient lung tissue. Additionally, they can be used to prepare synthetic peptides for surfactant compositions and to deliver therapeutic agents effectively.
Career Highlights
Throughout his career, Jason has worked with prestigious institutions such as the University of Rochester and the University of Guelph. His research has focused on developing advanced solutions for respiratory health, showcasing his commitment to innovation in medical science.
Collaborations
Jason has collaborated with esteemed colleagues, including Robert H Notter and Zhengdong Wang. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Jason A Davy's work in synthetic lung surfactants represents a significant advancement in respiratory treatment options. His innovative patents and collaborations highlight his dedication to improving health outcomes through scientific research.